Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shutoku Matsuyama and Yuriko Tomita.
Shutoku Matsuyama
Connection Strength
1.227
Yuriko Tomita
  1. The anti-influenza virus drug favipiravir has little effect on replication of SARS-CoV-2 in cultured cells. Antimicrob Agents Chemother. 2021 Mar 01.
    View in: PubMed
    Score: 0.932
  2. The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection. J Virol. 2021 05 24; 95(12).
    View in: PubMed
    Score: 0.237
  3. Performance Evaluation of Real-Time RT-PCR Assays for the Detection of Severe Acute Respiratory Syndrome Coronavirus-2 Developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):465-472.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.